IL-13 priming in precursors drives beige adipogenesis and enhances metabolic homeostasis
Journal of Clinical Investigation · 2025
DOI: 10.1172/jci191361 ↗Kurz gefasst
Kommentar in der Zeitschrift Journal of Clinical Investigation, 2025. Verfasst von Margo P Emont und 1 weiteren Autor:innen. Beteiligte Einrichtung: Department of Medicine, Section of Endocrinology, Diabetes and Metabolism, University of Chicago, Chicago, Illinois, USA. Hauptthemen laut MEDLINE: Adipogenesis, Interleukin-13, Homeostasis, Adipocytes, Beige. Die Arbeit wurde bisher 2-mal zitiert (Crossref) und nennt 21 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0). Gefördert von: NIDDK NIH HHS, NIAAA NIH HHS.
Abstract (Originalsprache)
Kein Abstract verfügbar.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Substanzen
Autor:innen und Institutionen
- Department of Medicine, Section of Endocrinology, Diabetes and Metabolism, University of Chicago, Chicago, Illinois, USA.
- Life Sciences Institute and.
- Department of Molecular and Integrative Physiology, University of Michigan, Ann Arbor, Michigan, USA.
Förderung
- NIDDK NIH HHS
- NIAAA NIH HHS
Zitieren
APA
Emont, M. P., & Wu, J. (2025). IL-13 priming in precursors drives beige adipogenesis and enhances metabolic homeostasis. Journal of Clinical Investigation. https://doi.org/10.1172/jci191361
Vancouver
Emont MP, Wu J. IL-13 priming in precursors drives beige adipogenesis and enhances metabolic homeostasis. Journal of Clinical Investigation. 2025. doi:10.1172/jci191361
BibTeX
@article{Emont2025,
author = {Emont, Margo P and Wu, Jun},
title = {IL-13 priming in precursors drives beige adipogenesis and enhances metabolic homeostasis},
journal = {Journal of Clinical Investigation},
year = {2025},
doi = {10.1172/jci191361}
}
EUVIMED